| Literature DB >> 35621842 |
Hugo Fernández-Rubio1, Ricardo Becerro-de-Bengoa-Vallejo1, David Rodríguez-Sanz1, César Calvo-Lobo1, Davinia Vicente-Campos2, José López Chicharro3.
Abstract
Coronary artery disease (CAD) may be considered a main cause of mortality and the prevalence of CAD is increasing nowadays, leading to high health costs in many countries. Despite the fact of the regression of the atherosclerotic plaque, the decrease in blood viscosity and the growth of collateral vessels have been proposed as improvements that CAD patients may obtain under exercise performance. Thus, the present narrative review aimed to carry out a brief specific analysis of the results achieved when performing endurance, strength or inspiratory muscle training. Exercise attenuates certain pathophysiological processes of this disease, such as endothelial dysfunction or the vulnerability of atherosclerotic plaques, and produces improvements in functional capacity and muscle strength, among others. Within the different exercise modalities, the most important parameter to be considered seems to be the total caloric expenditure, and not so much the modality itself. As such, in cardiac rehabilitation, when prescribing exercise, we should possibly focus on the modality that obtains more adherence in patients. To conclude, it must be highlighted that total caloric expenditure is not being taken into account when comparing interventions and this relevant information should be considered in future studies.Entities:
Keywords: aerobic training; coronary artery disease; exercise; resistance training; respiratory muscle training
Year: 2022 PMID: 35621842 PMCID: PMC9146277 DOI: 10.3390/jcdd9050131
Source DB: PubMed Journal: J Cardiovasc Dev Dis ISSN: 2308-3425
Figure 1Beneficial effects of exercise training on the CAD risk factors including inflammation, sympathetic activity and endothelial dysfunction. Created with BioRender.com accessed on 1 March 2022. CAD: Coronary artery disease; PSNS: parasympathetic nervous system; HRV: heart rate variability; HRR: heart rate recovery; CFVR: coronary blood flow velocity reserve; CRP: C-reactive protein; VWF: Von Willebrand Factor; FG: fibrinogen.
Effects of aerobic training in patients with artery coronary disease.
| Studies | Groups | Parameters Improving Significantly ( | Parameters Not Improving Significantly ( |
|---|---|---|---|
| Chen, 2017 | AT vs. CG | Peak VO2, LDL-C, HDL-C, LVEF and SBP | DBP, triglycerides and total cholesterol levels |
| Kraal, 2017 | AT vs. CG | Peak VO2 | - |
AT: aerobic training; CG: control group; DBP: diastolic blood pressure; LVEF: left ventricular ejection fraction; SBP: systolic blood pressure.
Effects of resistance training in patients with coronary artery disease.
| Studies | Groups | Parameters Improving Significantly ( | Parameters Not Improving Significantly ( |
|---|---|---|---|
| Yamamoto, 2016 | (Older) RCT vs. AT | Peak VO2, lower extremity strength, time of exercise and mobility | - |
| (Middle-aged) RCT vs. AT | Peak VO2, lower extremity strength and time of exercise | Mobility | |
| Fan, 2021 | RT vs. CG | Peak VO2, quality of life, LVEF and LVEDD | - |
| RT vs. AT | Anaerobic threshold and LVEF | Peak VO2 and quality of life | |
| CT vs. AT | Peak VO2, quality of life in the physical and global component, upper and lower body muscle strength, anaerobic threshold and LVEF | Maximal VO2, the emotional component of quality of life, and LVEDD | |
| Hollings, 2017 | RT vs. CG | Upper and lower body muscle strength | - |
| RT vs. AT | - | Peak VO2 and work capacity | |
| CT vs. AT | Maximal work capacity and upper and lower body muscle strength | Peak VO2 | |
| Xanthos, 2017 | RT vs. AT | - | Peak VO2 and muscle strength |
| CT vs. AT | Peak VO2, maximal work capacity and muscle strength | - | |
| Marzolini, 2012 | CT vs. AT | Maximal exercise capacity, ventilatory threshold, fat-free mass and upper and lower body muscle strength | Peak VO2 |
AT: aerobic training; CG: control group; CT: combination of RT and AT; LVEDD: the left ventricular end-diastolic dimension; LVEF: left ventricular ejection fraction; RCT: resistance training or combined training; RT: resistance training.
Effects of inspiratory muscle training in patients with coronary artery disease.
| Studies | Groups | Parameters Improving Significantly ( | Parameters Not Improving Significantly ( |
|---|---|---|---|
| Dos Santos, 2019 | IMT vs. CG | MIP, peak VO2, 6MWT, FRAP and MLHFQ | SMIP, CRP, NOx and AOPP |
| Hulzebos, 2006 [ | IMT vs. CG | MIP and post-operative pulmonary complications | FVC, FEV1, VC and length of hospital stay |
| Hulzebos, 2006 [ | IMT vs. CG | MIP, SMIP, post-operative pulmonary complications and length of hospital stay | - |
| Stein, 2009 | IMT vs. CG | MIP, MEP, peak VO2, 6MWT, FVC and FEV1 | - |
| Turky, 2017 | IMT vs. CG | MIP, alveolar-arterial oxygen gradient and oxygen saturation | - |
| Valkenet, 2017 | IMT vs. CG | MIP, post-operative pulmonary complications and length of hospital stay | SF-36 questionnaire and EQ-5D-3L |
| Savci, 2011 | IMT vs. CG | MIP, 6MWT, length of hospital stay, duration in intensive care, NHP (sleep) and HADS (anxiety) | FVC, FEV1, FEV1/FVC, NHP (emotional reactions, pain, energy, social isolation and physical mobility) and HADS (depression) |
| Weiner, 1998 | IMT vs. CG | MIP and SMIP | FVC and FEV1 |
| Miozzo, 2018 | AT + IMT vs. AT | MIP | MEP, peak VO2, 6MWT, muscle strength and SF-36 questionnaire |
| Matheus, 2012 | IMT vs. CG | VC and TV | MIP, MEP and MEF |
| Hermes, 2015 | IMT | MIP, MEP, peak VO2 and MLHFQ | - |
6MWT: 6-min walk test; AOPP: oxidant profile; AT: aerobic training; CG: control group; CRP: C-reactive protein; FEV1: maximum expiratory volume in the first second; FRAP: antioxidant profile; FVC: forced vital capacity; HADS: Hospital Anxiety and Depression Scale; IMT: inspiratory muscle training; MEF: maximum expiratory flow; MEP: maximum expiratory pressure; MIP: maximum inspiratory pressure; MLHFQ: Minnesota Living with Heart Failure Questionnaire; NHP: Nottingham Health Profile; NOx: endothelial function; SMIP: inspiratory muscle resistance; VC: vital capacity; TV: tidal volume.
Prescription of Aerobic training.
| Variable | Recommendation, CAD Patient | Recommendation, Healthy Subject |
|---|---|---|
| Mode | Continuous aerobic training | |
| Frequency | Three to five sessions per week | |
| Duration | 20–60 min per session | |
| Intensity |
10 bpm below the HR associated with any signs or symptoms Resting HR plus 20 bpm or 30 bpm RPE 11–13 (first sessions) RPE 12–15 (next sessions) |
55%/65% to 90% maximal HR 40%/50% to 85% maximal VO2R |
bpm: beats per minute; CAD: coronary artery disease; HR: Heart rate; VO2R: Maximum Reserve Oxygen Consumption; RPE: Rating of perceived exertion.
Prescription of resistance training.
| Variable | Recommendation, CAD Patient | Recommendation, Healthy Subject |
|---|---|---|
| Frequency | Two or three times per week | Two times per week |
| Sets/Repetitions | 1–2 sets/12–15 repetitions | 2–3 sets/8–12 repetitions |
| Loads | 40–50% of the 1 RM | 60–80% of the 1 RM |
CAD: coronary artery disease; RM: maximum resistance.